CO.DON AG
DGAP-Ad-hoc: CO.DON AG / Key word(s): Market launch CO.DON AG (ISIN: DE DE000A1K0227) CO.DON AG signs term sheet with Haemo Pharma GmbH for the distribution of Spherox in Austria Berlin / Teltow, 12 June 2018 - CO.DON AG is in final stage negotiations with Haemo Pharma GmbH concerning the exclusive distribution in Austria of Spherox, a cell-based pharmaceutical for which central EU marketing authorisation has been granted. The parties signed a term sheet today governing the key elements of their potential collaboration and of a distribution agreement, which now has to be refined in detail. By signing the distribution agreement, with an initial term of 5 years, CO.DON AG would generate at least a guaranteed cash inflow in the first two years of (all in all) approximately 17% of the revenue in the financial year 2017 (revenue in 2017: kEUR 5,964). From 2020, cash inflow will depend on the development of the state reimbursement situation. The distribution agreement is subject to the approval of the Supervisory Board of CO.DON AG.
Notifier:
12-Jun-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | CO.DON AG |
| Warthestraße 21 | |
| 14513 Teltow | |
| Germany | |
| Phone: | 03328 43460 |
| Fax: | 03328 434643 |
| E-mail: | info@codon.de |
| Internet: | www.codon.de |
| ISIN: | DE000A1K0227 |
| WKN: | A1K022 |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |
694807 12-Jun-2018 CET/CEST
